Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis

Abstract Human parainfluenza virus (HPIV) infection as an aetiology of acute viral myocarditis is rare, with only few cases reported in the literature to date. Here we report a case of fulminant HPIV-2 myocarditis in a 47 year-old man with viraemia who was successfully treated with intravenous ribavirin and intravenous immunoglobulin (IVIG). There are currently no recommendations on the treatment of HPIV myocarditis. We are, to our knowledge, the first to report a patient with a documented HPIV-2 viraemia that subsequently cleared after the initiation of antiviral therapy. Although it is difficult to definitively attribute the patient's clinical improvement to ribavirin or IVIG alone, our case does suggest that clinicians may wish to consider initiating ribavirin and IVIG in patients with HPIV myocarditis and persistent viraemia not responding to supportive measures alone.

[1]  R. Holubkov,et al.  Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy , 2001, Circulation.

[2]  Iikka Julkunen.  Serological diagnosis of parainfluenza virus infections by enzyme immunoassay with special emphasis on purity of viral antigens , 1984, Journal of medical virology.

[3]  T. Welte,et al.  Influenza and other respiratory virus infections in solid organ transplant recipients , 2014, Clinical Microbiology and Infection.

[4]  R. Kandolf,et al.  High Prevalence of Viral Genomes and Multiple Viral Infections in the Myocardium of Adults With “Idiopathic” Left Ventricular Dysfunction , 2005, Circulation.

[5]  Heribert Schunkert,et al.  Left-ventricular dysfunction , 1998, The Lancet.

[6]  F. Pozo,et al.  Myocarditis Caused by Human Parainfluenza Virus in an Immunocompetent Child Initially Associated with 2009 Influenza A (H1N1) Virus , 2011, Journal of Clinical Microbiology.

[7]  D. Wilks,et al.  Myopericarditis associated with parainfluenza virus type 3 infection , 1998, European Journal of Clinical Microbiology and Infectious Diseases.

[8]  A. Demetris,et al.  Intravenous immune globulin in the therapy of myocarditis and acute cardiomyopathy. , 1997, Circulation.

[9]  A. Gratwohl,et al.  Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  V. Ruppert,et al.  Management of fulminant myocarditis: A diagnosis in search of its etiology but with therapeutic options , 2014, Current Heart Failure Reports.

[11]  Human parainfluenza virus in patients with influenza-like illness from Central and South America during 2006–2010 , 2013, Influenza and other respiratory viruses.

[12]  F. Otsu,et al.  [A case of parainfluenza viral myocarditis showing various kinds of conduction disturbances (author's transl)]. , 1978, Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine.

[13]  N. Lévêque,et al.  Viral causes of human myocarditis. , 2009, Archives of cardiovascular diseases.

[14]  F. Chiang,et al.  Myopericarditis Associated with Parainfluenza Virus Type I Infection , 2006 .

[15]  M. Tominaga,et al.  Combination treatment with ribavirin and interferon for coxsackievirus B3 replication. , 1992, The Journal of laboratory and clinical medicine.